Thursday September 20, 2018 02:09

Heathcare Press Release : 01 Oct 2015

Photo Release: Bangkok Bank invites customers to join the Check-Up for Charity Project Proceeds go to Pattani Hospital Foundation Heathcare—01 Oct 15

Bangkok Bank Third Regional Metropolitan Area Manager Yuttapong Phoomborplub (right), Bangkok Bank Siriraj Piyamaharajkarun Hospital branch manager Narisa Laowpanich (left), the Friends for Friends' Club President Clinical Professor (Emeritus) Dr.

Merck Agrees to Return Kuvan(R) Rights to BioMarin Pharmaceutical to Strengthen Focus on Core Business Heathcare—01 Oct 15

DARMSTADT, Germany--1 Oct--PRNewswire/InfoQuest

Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced that it has reached an agreement with BioMarin Pharmaceutical, Inc., San Rafael, California, U.S., to return the rights to Kuvan(R), used to treat phenylketonuria (PKU), a rare metabolism disorder, as the company focuses its healthcare business on core areas.

In addition to Kuvan(R), the two companies agreed that Merck will return its option to develop and commercialize Peg-Pal, an investigational drug that is also designed for the treatment of PKU, an autosomal recessive genetic disorder caused by either a defect or a deficiency of the enzyme phenylalanine hydroxylase or its co-factor tetrahydrobiopterin. Merck will receive an upfront payment of EUR 340 million, equal to five times its annual sales, for Kuvan(R), plus up to EUR 185 million in additional milestones for both products. The agreement is expected to become effective Jan. 1, 2016.

"Returning

Asia Pacific MedTech Forum 2015 Open for Registration Heathcare—01 Oct 15

Registration is now open for Asia Pacific MedTech Forum 2015, the region's first event of its kind for the fast-growing medical devices and diagnostics industry. Announced by the Asia Pacific Medical Technology Association (APACMed) today, this inaugural